Clinical Trial Update: Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating nab-paclitaxel in combination with S-1 for advanced pancreatic cancer; the current trial status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN